BrunoBastosMD

Oncology • Miami, FL

Genitourinary Oncology

Staff

Join to view full profile

Dr. Bastos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bastos' full profile

Already have an account?

Office
Mount Sinai Medical Center
4300 Alton Rd
Miami, FL 33140
Phone+1 305-535-3300

Education & Training

Harvard Medical SchoolFellowship, Development Therapeutics, 2008 - 2009
Jackson Health System2005 - 2008
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2002 - 2005
Federal University of Bahia Faculty of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2009 - 2025
MA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors Start of enrollment: 2017 Dec 06
Active, not recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec
Cancer Research Communications. 2024-05-30
2 citations
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas B Karasic, Oxana V Crysler
Cancer Research Communications. 2024-04-18
Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
Margaret Meagher, Harris Krause, Andrew Elliott, Alex Farrell, Emmanuel S Antonarakis
Cancer Medicine. 2024-04-01

Press Mentions

Using Your Immune System to Fight Cancer Is Showing Significant PromiseMay 26th, 2017
Cleveland Clinic Cancer DoctorNovember 13th, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

External Links

ABIMhttps://www.abim.org/verify-physician.aspx?type=id&id=259861